Financhill
Back

Atlas Arteria Vs. Repligen Industry Stock Comparison

Sell
13

MAQAF
Atlas Arteria

Last Price:
3.09
Seasonality Move:
2.66%
Sell
30

RGEN
Repligen

Last Price:
124.90
Seasonality Move:
7.3%
Sell
13
Atlas Arteria (MAQAF) is a Sell

Is Atlas Arteria a Buy, Sell or Hold?

  • The current Atlas Arteria [MAQAF] share price is $3.09. The Score for MAQAF is 13, which is 74% below its historic median score of 50, and infers higher risk than normal.
  • MAQAF is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
30
Repligen (RGEN) is a Sell

Is Repligen a Buy, Sell or Hold?

  • The current Repligen [RGEN] share price is $124.73. The Score for RGEN is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • RGEN is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

MAQAF Stock Price Chart

What is Atlas Arteria's stock price today?

  • The Atlas Arteria share price today is $3.09
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MAQAF is experiencing slight buying pressure.

RGEN Stock Price Chart

What is Repligen's stock price today?

  • The Repligen share price today is $124.73
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RGEN is experiencing selling pressure, which indicates risk of future bearish movement.

MAQAF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.01 Buy
Relative Strength Index (14 RSI): 39.34 Sell
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (3.13 - 3.37) Sell
Bollinger Bands (100): (3.12 - 3.5) Sell

RGEN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.46 Sell
Relative Strength Index (14 RSI): 36.22 Sell
Chaikin Money Flow: -1285419 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (134.94 - 146.38) Sell
Bollinger Bands (100): (130 - 153.64) Sell

MAQAF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 3.29 Sell
20-day SMA: 3.24 Sell
50-day SMA: 3.2 Sell
200-day SMA: 3.4 Sell
8-day EMA: 3.25 Sell
20-day EMA: 3.25 Sell
50-day EMA: 3.25 Sell
200-day EMA: 3.42 Sell

RGEN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 142.02 Sell
20-day SMA: 140.23 Sell
50-day SMA: 141.19 Sell
200-day SMA: 157.58 Sell
8-day EMA: 139.7 Sell
20-day EMA: 140.54 Sell
50-day EMA: 141.71 Sell
200-day EMA: 151.3 Sell

Atlas Arteria Earnings Growth & MAQAF Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Repligen Earnings Growth & RGEN Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.19 per share, and an increase next year of $0.22 per share.

Atlas Arteria Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Repligen Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):